Loading…
Based on limited metadata, the FDA issued a Warning Letter to Celletech, Ltd on August 28, 2018, regarding an unspecified product category classified as "Other." Without access to the full letter text or detailed subject information, the specific nature of the regulatory violations cannot be determined from the available metadata. The issuing office is also not identified in the provided information, limiting visibility into the specific regulatory division's concerns. To understand the full scope and details of the violations cited, the complete Warning Letter would need to be reviewed.